| Tag | Content |
|---|
EnhancerAtlas ID | HS105-63525 |
Organism | Homo sapiens |
Tissue/cell | IMR90 |
Coordinate | chr5:34516900-34517770 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| FOSL1 | MA0477.1 | chr5:34517439-34517450 | CATGAGTCACC | - | 6.62 | | FOXP1 | MA0481.2 | chr5:34517194-34517206 | ATCTGTTTACTT | - | 6.74 | | FOXP2 | MA0593.1 | chr5:34517195-34517206 | TCTGTTTACTT | - | 6.32 | | JUND | MA0491.1 | chr5:34517439-34517450 | CATGAGTCACC | - | 6.02 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_01891 | chr5:34516373-34517767 | Aorta | | SE_33763 | chr5:34516177-34518028 | HCC1954 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH05I034517 | chr5 | 34517505 | 34517706 |
|
Enhancer Sequence | ACAGTGGCCT CTAGGGTCAC ATACCACCGG CTTCCCTCCT CCTTGATCGC TCTTTTCCAG 60
TTATGTTGCC TCCTTGGCTG GCCTTCCAAC AAGTCAGCCC TGCTCCACTG CTTAGGGCCC 120
TCGTGCTCCA CCCACATGCC TTGCTGCCTC ATTTCCTTCA GATTTCTGAT CGGATACCGC 180
TTATCAAAGA GGACTTCTCT GACCATCCTC CAGGAAATAT CAGATCTCGT GCTCATTCTG 240
CCTCCTCTTT CCATTACACT ATTCCTTTAT AGTCCTTGCC ATAGCCTGGT ATATATCTGT 300
TTACTTGCTA TTGTCTGTCT CCTCTGCTGA AATGTAAGCT CCAGGGGGGC AGAGACTCTC 360
ATTCAGTTTT TGCCAGTCAC TAGATAACAC ACACACATAT ATTTTAAAGT CAAACAAAAA 420
AACTTCTATT TTATTTATTG TCAGAAATGG GGTCTTGCTA TGTTGCTCAG GCTAGTCTCA 480
GAACTCCTGA TTTTAAGTGA TCCTTCCTTC TCAGCCTCCT GAATAGCTGA AATTACAGGC 540
ATGAGTCACC ATGCCCGGCT TATTTATTTA TATTTGATTA CTGATTCTGT TCTTCCTCTT 600
GAGTGTCATC ATCATCCTAT CCCGTTTCTA TTTCCAAAGC CACACATCAG CTCAGTTGAT 660
CACCATCCCT TGCCTGCATT ACTGCAGCAG ACTTCTTAAG AGCCCCACCT ACAGTCCTGC 720
AGTCTAAAAT AATCTAACTC CATACACTCT TTGTCAAGTC ACCTTACTGA TTAGGAACCT 780
ACTATGTCAG TGTAAATTGA TACTAACTCT ATGGAGGGCA ATTGTCATTA TCTTTCAAAA 840
TGATGTGTCT ACCATTTGAC TCATTTGATC 870
|
